SIREN : 450763693
AZUR SANTE is a French company founded 22 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in NICE (06000), this company of category PME shows in 2016 a revenue of 1.6 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-09
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | N/C | N/C | N/C | N/C | N/C | N/C | N/C | N/C | 1 596 548 € |
| Net income | 77 855 € | 47 776 € | 111 722 € | 182 916 € | 136 618 € | 48 874 € | 53 706 € | 78 003 € | 86 912 € |
| EBITDA | N/C | N/C | N/C | N/C | N/C | N/C | N/C | N/C | 112 271 € |
| Net margin | N/C | N/C | N/C | N/C | N/C | N/C | N/C | N/C | 5.4% |
In 2024, AZUR SANTE generates positive net income of 78 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 87 k€ -> 78 k€.
77 855 €
The debt ratio (= Financial debt / Equity x 100) stands at 53%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 56%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
52.898%
56.256%
56.3%
In 2024, the debt ratio of AZUR SANTE (52.90) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
In 2024, the financial autonomy of AZUR SANTE (56.3%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
The liquidity ratio (= Current assets / Current liabilities) stands at 102.11. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
102.112
In 2024, the liquidity ratio of AZUR SANTE (102.11) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
0 €
0 j
0 j
0 j
Based on 225 transactions of similar company sales in 2024, the value of AZUR SANTE is estimated at 1 086 913 € (range 756 909€ - 1 626 084€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Only this financial indicator is available for this company.
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare AZUR SANTE with other companies in the same sector:
The revenue of AZUR SANTE in 2016 is 1.6 M€.
Yes, AZUR SANTE generated a net profit of 78 k€ in 2024.
The headquarters of AZUR SANTE is located in NICE (06000), in the department Alpes-Maritimes.
The tax return of AZUR SANTE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
AZUR SANTE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.